In addition, inactivating mutations identified in the HAT gene EP300 have been implicated in a wide array of cancer types including diffuse large B cell lymphoma [34], head and neck, esophageal, colorectal, medulloblastoma and non-small cell lung carcinoma [7, 15]. This evidence concerns the gene TMPRSS11D and non-small cell lung carcinoma.